FDA Adverse Event Malfunction Summary report: N

BD BBL¿ EGG YOLK TELLURITE ENRICHMENT

MDR report key: 13524212 · Received February 14, 2022

Report

Report Number
1119779-2022-00232
Event Type
Malfunction
Date Received
February 14, 2022
Date of Event
December 22, 2021
Report Date
June 13, 2022
Manufacturer
BECTON, DICKINSON & CO. (SPARKS)
Product Code
JSK
PMA / PMN Number
PREAMENDMENT
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
EC
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

A DEVICE EVALUATION IS ANTICIPATED BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.

Additional Manufacturer Narrative · 0

H6: INVESTIGATION SUMMARY MATERIAL 212357 IS PREPARED USING A CONCENTRATED EGG YOLK EMULSION. THE EGGS ARE CLEANED, CRACKED AND SEPARATED BY HAND. ALTHOUGH THE EGG CRACKING PROCESS IS NOT STERILE OR PERFORMED IN A STERILE ENVIRONMENT, THE PROCESS WAS DEVELOPED TO MINIMIZE BIOBURDEN IN THE EGG YOLK PROCESS. THE EMULSION IS MIXED PER STANDARD OPERATING PROCEDURE (SOP). FILLING AND CAPPING ARE PERFORMED WITHIN THE ASEPTIC PROCESSING AREA. THE MEDIA IS MANUALLY DISPENSED INTO HEAT PROCESSED BOTTLES. CAPS ARE PLACED MANUALLY ON THE BOTTLES AND HAND TIGHTENED. PRODUCT IS TORQUED BY MACHINE LABELED. BOTTLES ARE INSPISSATED USING A VALIDATED CYCLE AND THEN PACKAGED IN A SEPARATE PACKING AREA. THE BATCH HISTORY RECORD REVIEW FOR BATCH 1301306 WAS SATISFACTORY AND NO QUALITY NOTIFICATIONS WERE GENERATED. FORMULATION, LABELING, AND PACKING PROCESSES WERE WITHIN SPECIFICATIONS. QC INSPECTION AND TESTING WERE SATISFACTORY AT TIME OF RELEASE. THE COMPLAINT HISTORY WAS REVIEWED, AND NO OTHER COMPLAINTS HAVE BEEN TAKEN ON THIS BATCH. RETENTION SAMPLES FROM BATCH 1301306 (6 BOTTLES) WERE AVAILABLE FOR INSPECTION. NO DEFECTS WERE OBSERVED FROM THE RETENTION SAMPLES. ALL 6/6 RETENTION BOTTLES HAD PROPERLY AFFIXED LEGIBLE LABELS. ONE PHOTO WAS RECEIVED TO ASSIST WITH THE INVESTIGATION: THE PHOTO SHOWS ONE BOTTLE. THE BOTTLE DOES NOT HAVE A LABEL. NO PRODUCT INFORMATION IS PRESENTED IN THE PHOTO.

Additional Manufacturer Narrative · 0

A DEVICE EVALUATION IS ANTICIPATED BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE BOTTLE OF BD BBL¿ EGG YOLK TELLURITE ENRICHMENT HAD NO LABEL ON IT. THERE WAS NO REPORT OF USER OR PATIENT IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER, TRANSLATED FROM SPANISH: "IN THE LAST IMPORTATION OF THE PRODUCT IDENTIFIED WITH CATALOG NO. 212357- TELLURITE EGG YOLK SOLUTION, PACKAGE OF 6 BOTTLES EACH WITH 100 ML, ONE OF THE BOTTLES ARRIVED WITHOUT AN EXTERNAL LABEL THAT ALLOWS THE CORRECT IDENTIFICATION OF THE CONTENT AND INFORMATION ON THE PRODUCT."

Description of Event or Problem · 0

IT WAS REPORTED THAT THE BOTTLE OF BD BBL¿ EGG YOLK TELLURITE ENRICHMENT HAD NO LABEL ON IT. THERE WAS NO REPORT OF USER OR PATIENT IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER, TRANSLATED FROM SPANISH: "IN THE LAST IMPORTATION OF THE PRODUCT IDENTIFIED WITH CATALOG NO. 212357- TELLURITE EGG YOLK SOLUTION, PACKAGE OF 6 BOTTLES EACH WITH 100 ML, ONE OF THE BOTTLES ARRIVED WITHOUT AN EXTERNAL LABEL THAT ALLOWS THE CORRECT IDENTIFICATION OF THE CONTENT AND INFORMATION ON THE PRODUCT."

Description of Event or Problem · 0

IT WAS REPORTED THAT THE BOTTLE OF BD (B)(6) TELLURITE ENRICHMENT HAD NO LABEL ON IT. THERE WAS NO REPORT OF USER OR PATIENT IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER, TRANSLATED FROM (B)(6): "IN THE LAST IMPORTATION OF THE PRODUCT IDENTIFIED WITH CATALOG NO. 212357- (B)(6) SOLUTION, PACKAGE OF 6 BOTTLES EACH WITH 100 ML, ONE OF THE BOTTLES ARRIVED WITHOUT AN EXTERNAL LABEL THAT ALLOWS THE CORRECT IDENTIFICATION OF THE CONTENT AND INFORMATION ON THE PRODUCT."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1082307 BD BBL¿ EGG YOLK TELLURITE ENRICHMENT SUPPLEMENT, CULTURE MEDIA JSK BECTON, DICKINSON & CO. (SPARKS) 1301306

Patients

Seq Age Sex Outcome Treatment
1 Unknown